Paper39737640
JAK inhibition decreases the autoimmune burden in Down syndrome.
Rachubinski AL and 21 others. Elife, 2024. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. JAK inhibition decreases the autoimmune burden in Down syndrome. Papers, record 39737640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39737640
- Disease
- atopic eczema238 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Down Syndrome | Major topic |
| Janus Kinase Inhibitors | Major topic |
| Piperidines | Major topic |
| Pyrimidines | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Young Adult | |
| Autoantibodies | |
| Autoimmunity | |
| Cytokines | |
| Pyrroles | |
| Middle Aged |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI150305 | NIAID NIH HHS | United States | R01AI150305 | PubMed and NIH | NIH RePORTER |
| R61AR077495 | NIAMS NIH HHS | United States | R61AR077495 | PubMed and NIH | NIH RePORTER |
| R01AI150305 | National Institute of Allergy and Infectious Diseases | R01AI150305 | PubMed and NIH | NIH RePORTER | |
| P30 CA046934 | NCI NIH HHS | United States | P30CA046934 | PubMed and NIH | NIH RePORTER |
| T32CA190216 | NCI NIH HHS | United States | T32CA190216 | PubMed and NIH | NIH RePORTER |
| R61 AR077495 | NIAMS NIH HHS | United States | R61AR077495 | PubMed and NIH | NIH RePORTER |
| UM1 TR004399 | NCATS NIH HHS | United States | UM1TR004399 | PubMed and NIH | NIH RePORTER |
| 2T32AR007411-31 | NIAMS NIH HHS | United States | T32AR007411 | PubMed and NIH | NIH RePORTER |
| R33 AR077495 | NIAMS NIH HHS | United States | R61AR077495 | PubMed and NIH | NIH RePORTER |
| T32 AR007411 | NIAMS NIH HHS | United States | T32AR007411 | PubMed and NIH | NIH RePORTER |
| T32 CA190216 | NCI NIH HHS | United States | T32CA190216 | PubMed and NIH | NIH RePORTER |
| UM1TR004399 | NCATS NIH HHS | United States | UM1TR004399 | PubMed and NIH | NIH RePORTER |
| P30CA046934 | NCI NIH HHS | United States | P30CA046934 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04246372 | Tofacitinib for Immune Skin Conditions in Down Syndrome | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 38946973 |
Source PubMed
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16901300 | Dermatological manifestations of Down's syndrome. | Clin Exp Dermatol | 2006 | https://conductscience.org/library/papers/16901300 | PubMed |
| 2 | 25612231 | Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. | Nat Protoc | 2015 | https://conductscience.org/library/papers/25612231 | PubMed |
| 3 | 33630031 | JAK inhibition for treatment of psoriatic arthritis in Down syndrome. | Rheumatology (Oxford) | 2021 | https://conductscience.org/library/papers/33630031 | PubMed |
| 4 | 36813963 | Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells. | Nature | 2023 | https://conductscience.org/library/papers/36813963 | PubMed |
| 5 | 23275362 | Early-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in Down syndrome. | Diabetes Care | 2013 | https://conductscience.org/library/papers/23275362 | PubMed |
| 6 | 39327647 | Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes. | Pediatr Dermatol | 2024 | https://conductscience.org/library/papers/39327647 | PubMed |
| 7 | 33093664 | Immune-mediated necrotizing myopathy: clinical features and pathogenesis. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/33093664 | PubMed |
| 8 | 18929686 | Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. | J Biomed Inform | 2009 | https://conductscience.org/library/papers/18929686 | PubMed |
| 9 | 33329559 | MAIT Cells in Barrier Tissues: Lessons from Immediate Neighbors. | Front Immunol | 2020 | https://conductscience.org/library/papers/33329559 | PubMed |
| 10 | 19358741 | flowCore: a Bioconductor package for high throughput flow cytometry. | BMC Bioinformatics | 2009 | https://conductscience.org/library/papers/19358741 | PubMed |
| 11 | 24860174 | Muscle-specific kinase (MuSK) autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction. | J Physiol | 2014 | https://conductscience.org/library/papers/24860174 | PubMed |
| 12 | 37147460 | Down syndrome: insights into autoimmune mechanisms. | Nat Rev Rheumatol | 2023 | https://conductscience.org/library/papers/37147460 | PubMed |
| 13 | 25011431 | Ten-year longitudinal study of thyroid function in children with Down's syndrome. | Horm Res Paediatr | 2014 | https://conductscience.org/library/papers/25011431 | PubMed |
| 14 | 9710446 | Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9710446 | PubMed |
| 15 | 29093484 | Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. | Sci Rep | 2017 | https://conductscience.org/library/papers/29093484 | PubMed |
| 16 | 37360690 | Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling. | iScience | 2023 | https://conductscience.org/library/papers/37360690 | PubMed |
| 17 | 29633736 | Thyroid Disorders in Subjects with Down Syndrome: An Update. | Acta Biomed | 2018 | https://conductscience.org/library/papers/29633736 | PubMed |
| 18 | 37277650 | Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model. | Nat Genet | 2023 | https://conductscience.org/library/papers/37277650 | PubMed |
| 19 | 32705346 | Down syndrome, accelerated aging and immunosenescence. | Semin Immunopathol | 2020 | https://conductscience.org/library/papers/32705346 | PubMed |
| 20 | 28259872 | Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome . | Horm Res Paediatr | 2017 | https://conductscience.org/library/papers/28259872 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42824469 | JAK Inhibitors for Alopecia Areata: Approved Therapies, Efficacy, and Unanswered Questions. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42824469 | PubMed |
| 42678586 | Immune Dysregulation in Down Syndrome: Implications for Infectious Susceptibility and Vaccine Response. | J Clin Immunol | 2026 | https://conductscience.org/library/papers/42678586 | PubMed |
| 42638456 | Fasudil induces anti-inflammatory transcriptomic changes and increased proliferation in human trisomy 21 neural progenitor cells. | Biol Open | 2026 | https://conductscience.org/library/papers/42638456 | PubMed |
| 42620150 | Progressive deterioration of adaptive immune repertoires in Down syndrome linked to interferon hyperactivity and lymphoid tissue disorganization. | bioRxiv | 2026 | https://conductscience.org/library/papers/42620150 | PubMed |
| 42496069 | The Mediator complex: co-transcriptional regulation and beyond. | RNA Biol | 2026 | https://conductscience.org/library/papers/42496069 | PubMed |
| 42459548 | Clinical considerations for immune dysregulation and immunodeficiency in Down syndrome. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42459548 | PubMed |
| 42343870 | Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome. | Expert Rev Neurother | 2026 | https://conductscience.org/library/papers/42343870 | PubMed |
| 42327181 | An AI-Powered Trisomy 21 Research Assistant. | bioRxiv | 2026 | https://conductscience.org/library/papers/42327181 | PubMed |
| 42317350 | Revisiting down syndrome through the lens of interferonopathy and innate immune dysregulation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317350 | PubMed |
| 42293324 | Immunosuppression in down syndrome regression disorder: a prospective observational cohort study. | Brain Commun | 2026 | https://conductscience.org/library/papers/42293324 | PubMed |
| 42266045 | Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies. | Curr Opin Rheumatol | 2026 | https://conductscience.org/library/papers/42266045 | PubMed |
| 42253980 | Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome. | Front Immunol | 2026 | https://conductscience.org/library/papers/42253980 | PubMed |
| 42250043 | Promoting Research Excellence in Down Syndrome: Proceedings of the 5th International Conference of the Trisomy 21 Research Society. | Neuromolecular Med | 2026 | https://conductscience.org/library/papers/42250043 | PubMed |
| 42169680 | How I Treat: Immune dysregulation in Down syndrome. | J Hum Immun | 2026 | https://conductscience.org/library/papers/42169680 | PubMed |
| 42156776 | Vaccination in individuals with Down syndrome: immune vulnerability, safety, efficacy and opportunities. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/42156776 | PubMed |
| 42115186 | Systematic multi-omic deconvolution of the clinical heterogeneity of Down syndrome. | Nat Commun | 2026 | https://conductscience.org/library/papers/42115186 | PubMed |
| 42092016 | Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better. | Pediatr Res | 2026 | https://conductscience.org/library/papers/42092016 | PubMed |
| 41889986 | Anti-inflammatory and pro-proliferative effects of fasudil in human trisomy 21 neural progenitor cells. | bioRxiv | 2026 | https://conductscience.org/library/papers/41889986 | PubMed |
| 41586519 | The Dp16 Down syndrome mouse model does not exhibit oral interferon-gammopathy or susceptibility to oral candidiasis. | mBio | 2026 | https://conductscience.org/library/papers/41586519 | PubMed |
| 41538324 | Altered hepatic metabolism in Down syndrome. | Cell Rep | 2026 | https://conductscience.org/library/papers/41538324 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| TOFACITINIB | CHEMBL221959 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL221959 |
Source ChEMBL
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39737640
GET https://conductscience.org/api/papers/v1/39737640/authors?page=2